Marker-free co-selection for successive rounds of prime editing in human cells.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
07 10 2022
Historique:
received: 03 12 2021
accepted: 27 09 2022
entrez: 7 10 2022
pubmed: 8 10 2022
medline: 12 10 2022
Statut: epublish

Résumé

Prime editing enables the introduction of precise point mutations, small insertions, or short deletions without requiring donor DNA templates. However, efficiency remains a key challenge in a broad range of human cell types. In this work, we design a robust co-selection strategy through coediting of the ubiquitous and essential sodium/potassium pump (Na

Identifiants

pubmed: 36207338
doi: 10.1038/s41467-022-33669-z
pii: 10.1038/s41467-022-33669-z
pmc: PMC9546848
doi:

Substances chimiques

DNA 9007-49-2
Sodium 9NEZ333N27
Sodium-Potassium-Exchanging ATPase EC 7.2.2.13

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5909

Subventions

Organisme : CIHR
Pays : Canada

Informations de copyright

© 2022. The Author(s).

Références

Elife. 2022 Feb 23;11:
pubmed: 35196219
PLoS Genet. 2021 Jun 14;17(6):e1009583
pubmed: 34125833
Cancer Res. 2010 Jan 1;70(1):288-98
pubmed: 20028854
Nat Biotechnol. 2020 Dec;38(12):1441-1450
pubmed: 32661439
Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):1755-60
pubmed: 25624492
Signal Transduct Target Ther. 2022 Apr 20;7(1):108
pubmed: 35440051
Nature. 2020 Apr;580(7804):542-547
pubmed: 32322059
Nat Commun. 2020 Oct 23;11(1):5352
pubmed: 33097693
Methods Enzymol. 2014;546:251-71
pubmed: 25398344
J Biol Chem. 2008 Nov 14;283(46):31861-70
pubmed: 18812319
Nat Commun. 2021 Jan 21;12(1):497
pubmed: 33479216
Genes Dev. 2021 Oct 1;35(19-20):1356-1367
pubmed: 34503990
Nucleic Acids Res. 2014 Dec 16;42(22):e168
pubmed: 25300484
Cancer Discov. 2014 May;4(5):546-53
pubmed: 24625776
Nat Biotechnol. 2022 Feb;40(2):189-193
pubmed: 33927418
G3 (Bethesda). 2016 Oct 13;6(10):3197-3206
pubmed: 27543296
J Biol Chem. 1996 Jul 5;271(27):15879-83
pubmed: 8663108
Science. 2012 Sep 28;337(6102):1634-7
pubmed: 23019645
Genome Biol. 2021 Jun 3;22(1):170
pubmed: 34082781
Genes (Basel). 2020 May 06;11(5):
pubmed: 32384610
CRISPR J. 2021 Feb;4(1):120-131
pubmed: 33571043
Nat Biotechnol. 2018 Jan;36(1):95-102
pubmed: 29176614
J Biol Chem. 1993 Dec 5;268(34):25632-5
pubmed: 8244998
Nat Rev Mol Cell Biol. 2020 Dec;21(12):765-781
pubmed: 33077885
Nat Commun. 2021 Apr 9;12(1):2121
pubmed: 33837189
Nat Methods. 2016 Dec;13(12):1036-1042
pubmed: 27798611
Cell. 2021 Oct 28;184(22):5635-5652.e29
pubmed: 34653350
Genes Dev. 2020 Jan 1;34(1-2):132-145
pubmed: 31805520
J Biol Chem. 1990 Apr 25;265(12):6638-41
pubmed: 2157705
Nat Commun. 2021 Jan 11;12(1):245
pubmed: 33431855
Cell Rep. 2013 Jan 31;3(1):138-47
pubmed: 23291097
N Engl J Med. 2012 Mar 8;366(10):883-892
pubmed: 22397650
Nat Commun. 2021 Aug 10;12(1):4843
pubmed: 34376693
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13742-7
pubmed: 19666591
Elife. 2020 Feb 28;9:
pubmed: 32109204
Nat Biotechnol. 2020 Jul;38(7):824-844
pubmed: 32572269
Cell Rep. 2015 Oct 20;13(3):621-633
pubmed: 26456817
Nat Methods. 2017 Jun;14(6):615-620
pubmed: 28417998
Nat Biotechnol. 2018 Oct;36(9):843-846
pubmed: 29813047
Mol Cell. 2020 Jan 16;77(2):210-212
pubmed: 31951546
G3 (Bethesda). 2017 Jan 5;7(1):87-93
pubmed: 27793971
Nature. 1995 Oct 5;377(6548):441-6
pubmed: 7566123
Nature. 2019 Dec;576(7785):149-157
pubmed: 31634902
Nat Biotechnol. 2021 Feb;39(2):198-206
pubmed: 32958957
Nat Biomed Eng. 2022 Feb;6(2):181-194
pubmed: 34446856
Nat Commun. 2022 Mar 24;13(1):1240
pubmed: 35332138
Nat Commun. 2017 Jan 09;8:13905
pubmed: 28067217
World J Stem Cells. 2015 Dec 26;7(11):1233-50
pubmed: 26730268
Nucleic Acids Res. 2021 Oct 11;49(18):10785-10795
pubmed: 34534334
Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):11911-6
pubmed: 26372961
Nat Protoc. 2022 Aug 8;:
pubmed: 35941224
EMBO J. 2017 Dec 15;36(24):3634-3649
pubmed: 29079701
Genome Res. 2013 Jul;23(7):1182-93
pubmed: 23568838
Nat Rev Genet. 2022 Mar;23(3):154-168
pubmed: 34611352
Nature. 2019 Oct;574(7778):409-412
pubmed: 31578524
N Engl J Med. 2014 Oct 9;371(15):1426-33
pubmed: 25295501
Nat Biotechnol. 2022 Mar;40(3):402-410
pubmed: 34608327
Nat Biotechnol. 2020 Jul;38(7):883-891
pubmed: 32433547
Science. 2020 Dec 4;370(6521):
pubmed: 33093214
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3514-9
pubmed: 17360675
Nat Commun. 2020 Jun 8;11(1):2876
pubmed: 32513994
Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):10958-63
pubmed: 23776223
Genetics. 2014 Nov;198(3):837-46
pubmed: 25161212
PLoS One. 2017 Jan 24;12(1):e0170445
pubmed: 28118392
Trends Biotechnol. 2019 Jan;37(1):56-71
pubmed: 30135027
Nat Commun. 2021 Feb 15;12(1):1034
pubmed: 33589617
Science. 2012 Aug 17;337(6096):816-21
pubmed: 22745249
Cell Rep. 2016 Jun 14;15(11):2340-7
pubmed: 27239032
Nat Commun. 2022 Feb 9;13(1):760
pubmed: 35140211
Mol Cell. 2017 Sep 21;67(6):1068-1079.e4
pubmed: 28890334
Nature. 2016 May 18;534(7606):272-6
pubmed: 27279227
J Biol Chem. 2003 Nov 21;278(47):47240-4
pubmed: 12972417
Science. 2013 Feb 15;339(6121):819-23
pubmed: 23287718
Cancer Discov. 2014 May;4(5):554-63
pubmed: 24631838
J Biol Chem. 2013 Mar 1;288(9):6511-21
pubmed: 23322780
Eur J Biochem. 1997 Sep 1;248(2):488-95
pubmed: 9346307
Cell. 2013 Sep 12;154(6):1380-9
pubmed: 23992846
CRISPR J. 2019 Aug;2:223-229
pubmed: 31328964
Genetics. 2014 Aug;197(4):1069-80
pubmed: 24879462
Curr Protoc Mol Biol. 2019 Sep;128(1):e100
pubmed: 31503414
Genes Dev. 2020 Jan 1;34(1-2):7-23
pubmed: 31896689

Auteurs

Sébastien Levesque (S)

Centre Hospitalier Universitaire de Québec Research Center-Université Laval, Québec, QC, G1V 4G2, Canada.
Université Laval Cancer Research Centre, Québec, QC, G1V 0A6, Canada.

Diana Mayorga (D)

Centre Hospitalier Universitaire de Québec Research Center-Université Laval, Québec, QC, G1V 4G2, Canada.
Université Laval Cancer Research Centre, Québec, QC, G1V 0A6, Canada.

Jean-Philippe Fiset (JP)

Centre Hospitalier Universitaire de Québec Research Center-Université Laval, Québec, QC, G1V 4G2, Canada.
Université Laval Cancer Research Centre, Québec, QC, G1V 0A6, Canada.

Claudia Goupil (C)

Centre Hospitalier Universitaire de Québec Research Center-Université Laval, Québec, QC, G1V 4G2, Canada.
Université Laval Cancer Research Centre, Québec, QC, G1V 0A6, Canada.

Alexis Duringer (A)

Centre Hospitalier Universitaire de Québec Research Center-Université Laval, Québec, QC, G1V 4G2, Canada.
Université Laval Cancer Research Centre, Québec, QC, G1V 0A6, Canada.

Andréanne Loiselle (A)

Centre Hospitalier Universitaire de Québec Research Center-Université Laval, Québec, QC, G1V 4G2, Canada.
Université Laval Cancer Research Centre, Québec, QC, G1V 0A6, Canada.

Eva Bouchard (E)

Centre Hospitalier Universitaire de Québec Research Center-Université Laval, Québec, QC, G1V 4G2, Canada.
Université Laval Cancer Research Centre, Québec, QC, G1V 0A6, Canada.

Daniel Agudelo (D)

Centre Hospitalier Universitaire de Québec Research Center-Université Laval, Québec, QC, G1V 4G2, Canada.
Université Laval Cancer Research Centre, Québec, QC, G1V 0A6, Canada.

Yannick Doyon (Y)

Centre Hospitalier Universitaire de Québec Research Center-Université Laval, Québec, QC, G1V 4G2, Canada. Yannick.Doyon@crchudequebec.ulaval.ca.
Université Laval Cancer Research Centre, Québec, QC, G1V 0A6, Canada. Yannick.Doyon@crchudequebec.ulaval.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH